openPR Logo
Press release

Genome Editing Therapy Market to Reach USD 31 Billion by 2034, Growing at a CAGR of 13.6%

12-03-2025 12:58 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Genome Editing Therapy Market

Genome Editing Therapy Market

Exactitude Consultancy's new report sheds light on the significant growth of the Genome Editing Therapy Market, driven by advancements in CRISPR technology and rising applications in genetic disorders and cancer research.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72646

Introduction:
Exactitude Consultancy's latest market research report on the Genome Editing Therapy Market provides an in-depth analysis of the current market dynamics, forecasting its growth from USD 9 billion in 2024 to USD 31 billion by 2034. This rapid growth is attributed to technological advancements in genome editing tools like CRISPR, TALEN, and ZFN, alongside increasing investments in genetic disorder treatments, cancer research, and agricultural biotechnology.

Key Market Stats & Insights:
• Market Size (2024): USD 9 Billion
• Market Size (2034): USD 31 Billion
• CAGR (2025-2034): 13.6%

• Key Segments:
o By Product Type: CRISPR, TALEN, ZFN
o By Application: Genetic Disorders, Cancer Research, Agricultural Biotechnology
o By End-User: Pharmaceutical Companies, Research Institutions, Academic Institutes
o By Technology: Molecular Cloning, Gene Delivery, Genetic Analysis
o By Distribution Channel: Online, Offline

• Largest Region: North America

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72646/genome-editing-therapy-market

Market Segmentation:
1. By Product Type: CRISPR is leading the market, with its superior precision and efficiency in editing genes. TALEN and ZFN are also showing strong growth, especially in agricultural biotechnology.
2. By Application: The genetic disorders segment is the largest, followed by cancer research, with genome editing offering transformative potential in both fields.
3. By Region: North America holds the largest market share, followed by Europe and the Asia Pacific region, which is anticipated to experience the highest growth during the forecast period.

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72646

Recent Developments in the Market:
• CRISPR technology has witnessed significant breakthroughs in gene editing, making it a key player in therapeutic applications.
• Increased funding and collaborations between academic institutions and pharmaceutical companies are accelerating the pace of clinical trials and product development.

Expert Quote:
"The Genome Editing Therapy Market is poised for exponential growth as advancements in gene-editing technologies open new possibilities in treating genetic disorders, cancer, and enhancing agricultural productivity," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Key Drivers and Restraints:
• Drivers: Rising prevalence of genetic disorders, technological advancements in CRISPR and other genome-editing technologies, increased R&D investment in cancer therapies, and growing applications in agricultural biotechnology.
• Restraints: Ethical concerns, high treatment costs, and regulatory challenges related to gene-editing technologies.

Market Forecast (2024-2034):
The Genome Editing Therapy Market is expected to grow at a CAGR of 13.6%, reaching USD 31 billion by 2034. This growth is fueled by innovations in gene-editing technologies like CRISPR and increased demand for treatments targeting genetic disorders and cancer.

Conclusion:
The Genome Editing Therapy Market holds immense potential, driven by cutting-edge technological innovations and growing applications in healthcare and agriculture. The market is expected to witness continued growth, opening new avenues for both researchers and pharmaceutical companies to explore.

This report is also available in the following languages : Japanese (骨髄細胞標的治療薬市場), Korean (骨髄細胞標的治療薬市場), Chinese (骨髄细胞标的治疗薬市场), French (Marché des thérapies ciblant les cellules myéloïdes), German (Markt für Therapien, die auf myeloide Zellen abzielen), and Italian (Mercato delle terapie mirate alle cellule mieloidi), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72646

Our More Reports:

Cutaneous Lupus Market
https://exactitudeconsultancy.com/reports/72690/cutaneous-lupus-market

Neuroendocrine Breast Tumor Market
https://exactitudeconsultancy.com/reports/72852/neuroendocrine-breast-tumor-market

Pharma Contract Research Organization (CRO) Services Market
https://exactitudeconsultancy.com/reports/72854/pharma-contract-research-organization-cro-services-market

Amnesia Market
https://exactitudeconsultancy.com/reports/72856/amnesia-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genome Editing Therapy Market to Reach USD 31 Billion by 2034, Growing at a CAGR of 13.6% here

News-ID: 4298887 • Views:

More Releases from Exactitude Consultancy

DNA Damage Response Market Growth Drivers, Emerging Therapies, and Competitive Landscape
DNA Damage Response Market Growth Drivers, Emerging Therapies, and Competitive L …
The DNA Damage Response (DDR) market is a rapidly evolving segment within the broader oncology and biopharmaceutical industries. DDR is a crucial mechanism within cells that helps maintain genomic integrity by repairing DNA damage caused by various internal and external factors, including radiation, chemicals, and replication errors. The market for DDR-targeting therapies is growing as an increasing number of cancer treatments focus on exploiting DDR pathways, particularly in tumors with
Porphyria Targeting Therapies Market Trends, Pipeline Insights, and Forecast
Porphyria Targeting Therapies Market Trends, Pipeline Insights, and Forecast
The Porphyria Targeting Therapies Market is a niche segment within the broader field of rare diseases and specialized therapeutic interventions. Porphyria refers to a group of rare, inherited disorders that result from a buildup of porphyrins in the body, leading to various health complications, including abdominal pain, neurological issues, and skin sensitivity. The targeting therapies for Porphyria aim to address these conditions by either correcting metabolic defects or alleviating the
Bronchial Spasm Market Dynamics and Emerging Therapies
Bronchial Spasm Market Dynamics and Emerging Therapies
Bronchial spasm refers to the sudden narrowing of the airways in the lungs, often associated with conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. This condition can lead to difficulty breathing, wheezing, and coughing, and is primarily caused by inflammation or hyperresponsiveness of the bronchial muscles. Bronchial spasms can be triggered by various factors, including allergens, irritants, infections, and even stress. Managing bronchial spasm involves
Nasal Drug Delivery Market to Reach USD 10.8 Billion by 2034, Growing at a CAGR of 5.5%
Nasal Drug Delivery Market to Reach USD 10.8 Billion by 2034, Growing at a CAGR …
Introduction: Exactitude Consultancy's latest market research report on the Nasal Drug Delivery Market offers a detailed analysis of the current market landscape and forecasts its growth from USD 6.2 billion in 2024 to USD 10.8 billion by 2034, growing at a robust compound annual growth rate (CAGR) of 5.5%. This report provides a deep dive into market segmentation, trends, drivers, and key players shaping the future of this evolving industry. Download Full

All 5 Releases


More Releases for Genome

Emerging Trends Influencing The Growth Of The Genome Editing/Genome Engineering …
The Genome Editing/Genome Engineering Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genome Editing/Genome Engineering Market Size Expected to Be by 2034? The size of the genome editing/genome engineering market has expanded swiftly in the past few years. Forecasts suggest the growth
Genome Editing/Genome Engineering Market 2023 - Size, Share, Segments, Data, Gro …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Genome Editing Or Genome Engineering Market Size, Growth Rate, And Forecast The global genome editing or genome engineering market size is expected to grow from $6.11 billion in 2022 to $7.20 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The genome editing or genome
Genome Editing & Genome Engineering Industry Research Report, Growth, Trends 202 …
Genome Editing & Genome Engineering Market 2028 Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments. Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Genome Editing & Genome Engineering estimated at US$ 3953 million in the year 2022, is projected to reach a revised size of US$ 6739.8 million by 2028,
Genome Editing/Genome Engineering Market Size - Industry Analysis Report 2021
Genome Editing/Genome Engineering Market Size, Capacity, Trends, Outlook, Research, Analysis, Growth | Industry Report 2021 Market Research Report to It’s a Database. Inquire Before Buying @ http://bit.ly/2uh3G7k The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with the
Genome Editing/Genome Engineering Market to experience hike in growth by 2024
Zion Market Research, the market research group announced the analysis report titled ‘Genome Editing/Genome Engineering Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024’ Global Genome Editing/Genome Engineering Market: Overview Genome editing/genome engineering refers to the techniques and strategies in which the DNA is deleted, replaced or inserted in the living organism’s genome with the help of molecular scissors or engineered nucleases. It is one of the active fields of
Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022
Qyresearchreports include new market research report "Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022" to its huge collection of research reports. The term healthcare has held a consistent definition over the many years of its development so far. However, the point at which this industry resides now is extremely advanced than the point it was at a few decades ago, thanks to the recent boom in technological advancements, the